Top 10 most sold midcap stocks by mutual funds, PMS and ULIPs. Do you own any?

Dalal Street's midcap stock debate intensifies as investors make strategic moves. Significant exits and new picks impact the market. Portfolio adjustments indicate shifting trends in the sector, with focus on specific stocks for potential growth and stability.

As the topic of whether the unputdownable rally in small and midcaps will lose sheen being the most debated one on Dalal Street, we screened out some of the most sold by long-term domestic institutional investors - , funds and .

Last month, saw the highest number of exits by 62 funds across MFs, PMSes and ULIPs, shows data pulled from the records of Finalyca by PMS Bazaar.

, Mphasis, NMDC and SAIL saw 31 exits each. Others in the top 10 list includes , Tata Communications, , and .


On the other hand, top new picks by funds included , , , BHEL, , , Voltas, , and .

In terms of portfolio weightage, fund exposure went up in midcaps went up in stocks like , Sona BLW Forging, Dixon Tech, United Spirits and Lupin and went down in Aurobindo Pharma, Ashok Leyland, Bharat Forge, UPL and Page Industries.

Also read |

After having a fantastic 2023, both mid and have been under pressure in the last one month with the Nifty Midcap index falling 7% and Nifty Smallcap index cracking about 10% amid concerns over a possible bubble building in the broader market.

Amid earnings headwinds, elevated valuations and neutral liquidity, analysts at Nuvama Institutional Equities say we may be at an inflexion point.

"This is owing to sharply decelerating SMID (small and midcap) profits as input price tailwinds fade while top-line recovery is getting delayed, moderating urban incomes (a strong pocket so far), and slowing India order book of industrial companies—which suggests domestic capex momentum could be peaking, hurting sentiment of cyclicals," said Prateek Parekh and Priyank Shah of Nuvama.

The next churn, they bet, is likely to be towards underperformed quality sectors like private banks, insurance and FMCG - the traditional defensives offering earnings resilience in a downturn.

Anand Rathi expects earnings growth of Nifty 50, Nifty Largecap 100, Nifty Midcap 150 and Nifty Smallcap 250 during 2024-25 and 2025-26 to be robust – in all cases above 11%.

"Even if we assume fair PE multiples of the respective indices would be significantly lower than the average forward PE multiples during similar phases of business cycles in the past, we do not observe any major froth in the Indian equity markets currently. On the contrary, Nifty Smallcap 250 seems to be trading significantly below the fair valuation," said Sweta Jain of Anand Rathi.

As far as earnings are concerned, the brokerage expects largecaps to deliver slightly better than average earnings growth in 2024-25. The smallcap index is likely to deliver the best earnings growth in 2025-26 while midcap earnings growth expectation is below its long-term average, it said.

Also read |

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Source: Stocks-Markets-Economic Times

Publicații recente
3 reasons why US may slip into a recession over the next 12 months
20.09.2024 - 16:00
Buffett's Berkshire Hathaway offloads more of its Bank of America stake
20.09.2024 - 16:00
Here's how the stock market typically performs in October
20.09.2024 - 16:00
Nokia says German court rules in its favour in Amazon patent dispute
20.09.2024 - 16:00
All you need to know about Fed easing cycles
20.09.2024 - 16:00
PodcastOne executive chairman buys $16,380 in company stock
20.09.2024 - 16:00
Here's how B Riley has started its coverage of internet names Snap and Reddit
20.09.2024 - 16:00
Morgan Stanley latest to downgrade ASML on China, memory, Intel concerns
20.09.2024 - 16:00
VinFast posts deeper Q2 loss on impairment charge, higher cost to boost sales
20.09.2024 - 16:00
Trump Media slides as lock-up expires
20.09.2024 - 16:00
Can the S&P 500 momentum continue?
20.09.2024 - 16:00
Sanofi's tolebrutinib drug delays progressive MS by 31% in trial
20.09.2024 - 15:00
Factbox-US companies to hire thousands of seasonal workers for holiday season
20.09.2024 - 15:00
FedEx, PepsiCo, Trump Media fall premarket; Nike rises
20.09.2024 - 15:00
Vietnamese EV maker VinFast reports wider sequential gross loss
20.09.2024 - 15:00

© Analytic DC. All Rights Reserved.

new
Analiza pieței Analiza complexǎ a petrolului WTI
Bine ați venit în mesageria de suport!!
*
*

Solicitarea dvs. a fost trimisă cu succes!
Veți fi contactat în scurt timp.